Editing Landmark studies (section)

== Non-Oncology ==

=== Andrology ===

* Testosterone Deficiency
**[https://test.urologyschool.com/index.php/Male_Reproductive_Physiology#TEAAM_(Testosterone's_Effects_on_Atherosclerosis_Progression_in_Aging_Men)_(JAMA_2015) TEAAM (Testosterone's Effects on Atherosclerosis Progression in Aging Men) JAMA 2015]
*Peyronie's Disease
**[https://test.urologyschool.com/index.php/Peyronie%27s_Disease#Intralesional_injection IMPRESS I & 2 (Clostridial collagenase (Xiaflex) trials)]

=== Functional ===

* MTOPS (combination alpha-blocker + 5ARI)
* CombAT (combination alpha-blocker + 5ARI)

=== Pediatrics ===

* RIVUR NEJM 2014 (antibiotic prophylaxis in VUR)

=== Other ===

* Mechanical Bowel Preparation for Elective Colorectal Surgery Cochrane Review 2011

=== Urogynecology and Reconstructive Pelvic Surgery ===
* Fecal Incontinence
**CAPABLE (biofeedback vs loperamide for FI)
*Mixed Urinary Incontinence
**ESTEEM (PT + Sling vs Sling alone)
*Pelvic Organ Prolapse
**OPTIMAL/eOPTIMAL (SSLF vs USLS for apical prolapse; PMFT vs no intervention for associated urinary symptoms)
**PESSRI (ring vs gelhorn pessary)
**SUPeR/eSUPeR (vaginal mesh hysteropexy vs TVH/USLS for POP)
*Prolapse Associated Incontinence
**CARE/eCARE (Burch + colpopexy vs colpopexy alone in women with preop SUI)
**OPUS (Vaginal POP surgery + TVT vs vaginal POP surgery alone)
*Non-neurogenic Overactive Bladder
**ABC (Anticholinergics vs Onabotulinum toxin A)
**ORBIT (PTNS vs Tolterodine ER)
**ROSETTA (Onabotulinum Toxin A 200u vs Interstim)
**SUMiT/STEP (PTNS vs Sham; PTNS longitudinal single arm)
*Stress Urinary Incontinence
**ATLAS (Continence pessary vs behavioral therapy vs Combined therapy)
**SISTeR (Burch vs fascial sling)
**TOMUS (retropubic vs. transobturator MUS)
**VALUE (office eval vs preop UDS for preop eval of uncomplicated SUI and MUS outcomes)
*Other
**Surgical Outcomes in Urogynecology-Assessment of Perioperative and Postoperative Complications Relative to Preoperative Hemoglobin A1c